Net Cash Provided by (Used in) Financing Activities in USD of INTERCEPT PHARMACEUTICALS, INC. from 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2023 was -$254K, a 20.1% increase year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$267M, a 24010% decline from 2021.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $1.12M.
  • INTERCEPT PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$693K, a 100% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$254K +$64K +20.1% 01 Jan 2023 31 Mar 2023 10-Q 27 Apr 2023
Q1 2022 -$318K +$765K +70.6% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q1 2021 -$1.08M -$330K -43.8% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q1 2020 -$753K -$905K -595% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 $152K -$329K -68.4% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q1 2018 $481K -$75K -13.5% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019
Q1 2017 $556K 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q1 2015 $195M +$192M +7813% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2015
Q1 2014 $2.46M +$2.37M +2713% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q1 2013 $87.4K +$146K 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014
Q1 2012 -$58.5K 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013

INTERCEPT PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$267M -$268M -24010% 01 Jan 2022 31 Dec 2022 10-K 02 Mar 2023
2021 $1.12M +$1.81M 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$693K -$458M -100% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023
2019 $458M +$194M +73.6% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022
2018 $264M +$261M +9186% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $2.84M -$412M -99.3% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020
2016 $414M -$151M -26.7% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019
2015 $565M +$374M +196% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018
2014 $191M +$125M +189% 01 Jan 2014 31 Dec 2014 10-K 02 Mar 2015
2013 $66.1M -$42.3M -39.1% 01 Jan 2013 31 Dec 2013 10-K 02 Mar 2015
2012 $108M +$109M 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015
2011 -$250K -$24.9M -101% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 $24.6M 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.